KalVista Pharmaceuticals, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Apr 30, 2025	FY2024 12 months to Apr 30, 2024	FY2023 12 months to Apr 30, 2023	FY2022 12 months to Apr 30, 2022	FY2021 12 months to Apr 30, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Stock-based compensation expense
Realized (gain) loss from sale of marketable securities
Non-cash operating lease expense
Amortization of premium on available for sale securities
Foreign currency exchange loss (gain)
Fair value adjustment to derivative liability
Non-cash interest expense and amortization of issuance costs
Changes in operating assets and liabilities:
Research and development tax credit receivable
Prepaid expenses and other assets
Other assets
Other receivables
Accounts payable
Accrued expenses
Deferred revenue

Net cash used in operating activities
Cash flows from investing activities:
Purchases of available for sale securities
Sales and maturities of available for sale securities
Acquisition of property and equipment
Capitalized website development costs
Net cash provided by investing activities
Cash flows from financing activities:
Proceeds from the royalty agreement
Issuance costs associated with the royalty agreement
Issuance of pre-funded warrants
Issuance of common stock from equity incentive plans
Net cash provided by financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents and restricted cash at beginning of year
Cash and cash equivalents and restricted cash at end of year
Supplemental disclosures of cash flow information:
Right of use assets obtained in exchange for operating lease liabilities
Website development costs included in accounts payable
Property and equipment included in accounts payable and accrued expenses:

Comments